7Baggers
 Best Biotech Stocks Right Now • Updated Daily  Benzinga Fri, 14 Nov 2025 12:01:00 GMT
 HC Wainwright Comments on Immix Biopharma FY2025 Earnings  Defense World Thu, 13 Nov 2025 06:36:13 GMT
 immix biopharma appoints commercial leader to head nxc-201 launch by investing.com  Investing.com Nigeria Thu, 13 Nov 2025 05:27:14 GMT
 Immix Biopharma appoints commercial leader to head NXC-201 launch  Investing.com Wed, 12 Nov 2025 14:31:20 GMT
 Immix Biopharma, Inc. SEC 10-Q Report  TradingView Fri, 07 Nov 2025 22:33:01 GMT
 Immix Biopharma: I Am Surprised To Reaffirm A 'Buy' (IMMX)  Seeking Alpha Thu, 06 Nov 2025 08:00:00 GMT
 immix biopharma (immx) expected to announce earnings on tuesday  MarketBeat Wed, 05 Nov 2025 16:32:05 GMT
 Immix Biopharma to present NXC-201 trial data for AL amyloidosis at ASH  Investing.com Australia Tue, 04 Nov 2025 13:25:07 GMT
 immix biopharma (nasdaq:immx) trading down 1.3% - time to sell?  MarketBeat Sat, 01 Nov 2025 08:34:21 GMT

Immix Biopharma
(NASDAQ:IMMX) 

IMMX stock logo

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. It is developing IMX-110 that is in Phase Ib/IIa clinical trials for the treatment of soft tissue sarcoma and...

Founded: 2012
IPO Price: $5 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends